Ologen DS 0.2% (Ophthalmic Solution)
5 ml drop: ৳ 180.00
Medicine Details
Category | Details |
---|---|
Generic | Olopatadine hydrochloride |
Company | General pharmaceuticals ltd |
Also available as |
Title and Categories
- Patadin Eye Drops
- Ologen DS Nasal Spray
- Ologen DS Tablet
- Olopatadine
- Antihistamine
- Allergy Relief Medication
- Ophthalmic Solution
- Nasal Spray
- Oral Tablet
- Non-Steroid Ophthalmic Drugs
Indications
- Treatment of allergic conjunctivitis
- Relief of symptoms of seasonal allergic rhinitis
- Relief of symptoms of allergic skin conditions
- Relief of symptoms of nasal allergies
- Treatment of vernal keratoconjunctivitis and keratitis
- Treatment of blepharitis and blepharoconjunctivitis
- Relief of itchy, watery, red, and swollen eyes and/or eyelids
- Relief of sneezing, itching, runny nose, and other nasal symptoms
Pharmacology
- Antagonist at histamine H1 receptors
- Mast cell stabilizer
- Inhibits immunologically-stimulated release of histamine
- Blocks histamine H1 receptor signaling pathway
- Reduces release of inflammatory mediators and cytokines
- Moderate protein binding in human serum
- Not extensively metabolized
- Plasma elimination half-life of 8 to 12 hours
Dosage
- 0.1%, 0.2%, 0.7% eye drop options
- Different dosing frequencies and intervals for eye drops
- Different dosing regimens for nasal spray based on age
- Tablet dosage for adults and children
- Instructions for missed doses
Administration
- Instructions for using nasal spray
- Cleaning procedures for nasal spray
- Caution against spraying nasal spray into the eyes
- Instructions for eye drop administration
Interaction
- No formal drug-drug interaction studies conducted
- Predominant elimination by renal excretion
- No expected interactions involving P450 inhibition
- No anticipated interactions with liver enzyme inhibitors
Contraindication
- Hypersensitivity to any component of the product
- Allergy to Olopatadine 5 mg tablet
- Consultation requirement for current medications and medical conditions
Side Effects
- Rarely reported headaches
- Adverse effects including blurred vision, burning or stinging sensation, dry eye, nausea, pruritus, rhinitis, and taste perversion
Pregnancy & Lactation
- Not teratogenic in rats and rabbits
- Usage in pregnant women justified by potential benefits vs. risks
- Caution in administration to nursing mothers
Precautions & Warnings
- Caution against wearing contact lenses with red eyes
- Avoidance of Ologen DS for contact lens-related irritation
- Benzalkonium Chloride absorption by soft contact lenses
- Ongoing consultation with the doctor for tablet usage
- Adherence to prescribed dosage and timing
- Consultation requirement before discontinuation of medication
Use in Special Populations
- No observed safety or effectiveness differences in geriatric use
Overdose Effects
- No specific information on Ologen DS overdose
- Advice to seek immediate medical attention for suspected overdose
Therapeutic Class
- Belonging to the category of Ophthalmic Non-Steroid drugs
Storage Conditions
- Store at room temperature
- Protection from light
- Desirable use within one month after opening
Related Brands
- Olon-DS 0.2% (Ophthalmic Solution) - kemiko-pharmaceuticals-ltd
- Olopan 0.1% (Ophthalmic Solution) - beximco-pharmaceuticals-ltd
- Olopan DS 0.2% (Ophthalmic Solution) - beximco-pharmaceuticals-ltd
- Olopta 0.1% (Ophthalmic Solution) - gaco-pharmaceuticals-ltd
- Olpadin 0.1% (Ophthalmic Solution) - aristopharma-ltd